Results: 1-22 |
Results: 22
5-HT6 receptor antagonists enhance retention of a water maze task in the rat
Authors: Rogers, DC Hagan, JJ
Citation: Dc. Rogers et Jj. Hagan, 5-HT6 receptor antagonists enhance retention of a water maze task in the rat, PSYCHOPHAR, 158(2), 2001, pp. 114-119
Long-term evaluation of isolation-rearing induced prepulse inhibition deficits in rats
Authors: Cilia, J Reavill, C Hagan, JJ Jones, DNC
Citation: J. Cilia et al., Long-term evaluation of isolation-rearing induced prepulse inhibition deficits in rats, PSYCHOPHAR, 156(2-3), 2001, pp. 327-337
Increased responsiveness of dopamine to atypical, but not typical antipsychotics in the medial prefrontal cortex of rats reared in isolation
Authors: Heidbreder, CA Foxton, R Cilia, J Hughes, ZA Shah, AJ Atkins, A Hunter, AJ Hagan, JJ Jones, DNC
Citation: Ca. Heidbreder et al., Increased responsiveness of dopamine to atypical, but not typical antipsychotics in the medial prefrontal cortex of rats reared in isolation, PSYCHOPHAR, 156(2-3), 2001, pp. 338-351
Central effects of urotensin-II following ICV administration in rats
Authors: Gartlon, J Parker, F Harrison, DC Douglas, SA Ashmeade, TE Riley, GJ Hughes, ZA Taylor, SG Munton, RP Hagan, JJ Hunter, JA Jones, DNC
Citation: J. Gartlon et al., Central effects of urotensin-II following ICV administration in rats, PSYCHOPHAR, 155(4), 2001, pp. 426-433
Clozapine enhances breakpoint in common marmosets responding on a progressive ratio schedule
Authors: Cilia, J Piper, DC Upton, N Hagan, JJ
Citation: J. Cilia et al., Clozapine enhances breakpoint in common marmosets responding on a progressive ratio schedule, PSYCHOPHAR, 155(2), 2001, pp. 135-143
Effects of centrally administered orexin-1 and orexinA: a role for orexin-1 receptors in orexin-B-induced hyperactivity
Authors: Jones, DNC Gartlon, J Parker, F Taylor, SG Routledge, C Hemmati, P Munton, RP Ashmeade, TE Hatcher, JP Johns, A Porter, RA Hagan, JJ Hunter, AJ Upton, N
Citation: Dnc. Jones et al., Effects of centrally administered orexin-1 and orexinA: a role for orexin-1 receptors in orexin-B-induced hyperactivity, PSYCHOPHAR, 153(2), 2001, pp. 210-218
Development of SHIRPA to characterise the phenotype of gene-targeted mice
Authors: Hatcher, JP Jones, DNC Rogers, DC Hatcher, PD Reavill, C Hagan, JJ Hunter, AJ
Citation: Jp. Hatcher et al., Development of SHIRPA to characterise the phenotype of gene-targeted mice, BEH BRA RES, 125(1-2), 2001, pp. 43-47
The effect of SB-269970, a 5-HT7 receptor antagonist, on 5-HT release fromserotonergic terminals and cell bodies
Authors: Roberts, C Allen, L Langmead, CJ Hagan, JJ Middlemiss, DN Price, GW
Citation: C. Roberts et al., The effect of SB-269970, a 5-HT7 receptor antagonist, on 5-HT release fromserotonergic terminals and cell bodies, BR J PHARM, 132(7), 2001, pp. 1574-1580
Anxiolytic profile of ropinirole in the rat, mouse and common marmoset
Authors: Rogers, DC Costall, B Domeney, AM Gerrard, PA Greener, M Kelly, ME Hagan, JJ Hunter, AJ
Citation: Dc. Rogers et al., Anxiolytic profile of ropinirole in the rat, mouse and common marmoset, PSYCHOPHAR, 151(1), 2000, pp. 91-97
Evaluation of the spontaneously hypertensive rat as a model of attention deficit hyperactivity disorder: acquisition and performance of the DRL-60s test
Authors: Bull, E Reavill, C Hagan, JJ Overend, P Jones, DNC
Citation: E. Bull et al., Evaluation of the spontaneously hypertensive rat as a model of attention deficit hyperactivity disorder: acquisition and performance of the DRL-60s test, BEH BRA RES, 109(1), 2000, pp. 27-35
The effect of SB-236057-A, a selective 5-HT1B receptor inverse agonist, onin vivo extracellular 5-HT levels in the freely-moving guinea-pig
Authors: Roberts, C Hatcher, P Hagan, JJ Austin, NE Jeffrey, P Wyman, P Gaster, LM Routledge, C Middlemiss, DN
Citation: C. Roberts et al., The effect of SB-236057-A, a selective 5-HT1B receptor inverse agonist, onin vivo extracellular 5-HT levels in the freely-moving guinea-pig, N-S ARCH PH, 362(2), 2000, pp. 177-183
Pharmacological actions of a novel, high-affinity, and selective human dopamine D-3 receptor antagonist, SB-277011-A
Authors: Reavill, C Taylor, SG Wood, MD Ashmeade, T Austin, NE Avenell, KY Boyfield, I Branch, CL Cilia, J Coldwell, MC Hadley, MS Hunter, AJ Jeffrey, P Jewitt, F Johnson, CN Jones, DNC Medhurst, AD Middlemiss, DN Nash, DJ Riley, GJ Routledge, C Stemp, G Thewlis, KM Trail, B Vong, AKK Hagan, JJ
Citation: C. Reavill et al., Pharmacological actions of a novel, high-affinity, and selective human dopamine D-3 receptor antagonist, SB-277011-A, J PHARM EXP, 294(3), 2000, pp. 1154-1165
Acute and chronic administration of the selective D-3 receptor antagonist SB-277011-A alters activity of midbrain dopamine neurons in rats: An in vivo electrophysiological study
Authors: Ashby, CR Minabe, Y Stemp, G Hagan, JJ Middlemiss, DN
Citation: Cr. Ashby et al., Acute and chronic administration of the selective D-3 receptor antagonist SB-277011-A alters activity of midbrain dopamine neurons in rats: An in vivo electrophysiological study, J PHARM EXP, 294(3), 2000, pp. 1166-1174
Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A potent and selective dopamine D-3 receptor antagonist with high oral bioavailability and CNS penetration in the rat
Authors: Stemp, G Ashmeade, T Branch, CL Hadley, MS Hunter, AJ Johnson, CN Nash, DJ Thewlis, KM Vong, AKK Austin, NE Jeffrey, P Avenell, KY Boyfield, I Hagan, JJ Middlemiss, DN Reavill, C Riley, GJ Routledge, C Wood, M
Citation: G. Stemp et al., Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A potent and selective dopamine D-3 receptor antagonist with high oral bioavailability and CNS penetration in the rat, J MED CHEM, 43(9), 2000, pp. 1878-1885
A novel, potent, and selective 5-HT7 antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)-ethyl)pyrrolidine-1-sulfonyl)phenol (SB-269970)
Authors: Lovell, PJ Bromidge, SM Dabbs, S Duckworth, DM Forbes, IT Jennings, AJ King, FD Middlemiss, DN Rahman, SK Saunders, DV Collin, LL Hagan, JJ Riley, GJ Thomas, DR
Citation: Pj. Lovell et al., A novel, potent, and selective 5-HT7 antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)-ethyl)pyrrolidine-1-sulfonyl)phenol (SB-269970), J MED CHEM, 43(3), 2000, pp. 342-345
Characterization of SB-269970-A, a selective 5-HT7 receptor antagonist
Authors: Hagan, JJ Price, GW Jeffrey, P Deeks, NJ Stean, T Piper, D Smith, MI Upton, N Medhurst, AD Middlemiss, DN Riley, GJ Lovell, PJ Bromidge, SM Thomas, DR
Citation: Jj. Hagan et al., Characterization of SB-269970-A, a selective 5-HT7 receptor antagonist, BR J PHARM, 130(3), 2000, pp. 539-548
[H-3]-SB-269970 - A selective antagonist radioligand for 5-HT7 receptors
Authors: Thomas, DR Atkinson, PJ Ho, M Bromidge, SM Lovell, PJ Villani, AJ Hagan, JJ Middlemiss, DN Price, GW
Citation: Dr. Thomas et al., [H-3]-SB-269970 - A selective antagonist radioligand for 5-HT7 receptors, BR J PHARM, 130(2), 2000, pp. 409-417
Use of SHIRPA and discriminant analysis to characterise marked differencesin the behavioural phenotype of six inbred mouse strains
Authors: Rogers, DC Jones, DNC Nelson, PR Jones, CM Quilter, CA Robinson, TL Hagan, JJ
Citation: Dc. Rogers et al., Use of SHIRPA and discriminant analysis to characterise marked differencesin the behavioural phenotype of six inbred mouse strains, BEH BRA RES, 105(2), 1999, pp. 207-217
Orexin A activates locus coeruleus cell firing and increases arousal in the rat
Authors: Hagan, JJ Leslie, RA Patel, S Evans, ML Wattam, TA Holmes, S Benham, CD Taylor, SG Routledge, C Hemmati, P Munton, RP Ashmeade, TE Shah, AS Hatcher, JP Hatcher, PD Jones, DNC Smith, MI Piper, DC Hunter, AJ Porter, RA Upton, N
Citation: Jj. Hagan et al., Orexin A activates locus coeruleus cell firing and increases arousal in the rat, P NAS US, 96(19), 1999, pp. 10911-10916
Influence of peptide CRF receptor antagonists upon the behavioural effectsof human rat CRF
Authors: Jones, DNC Kortekaas, R Hatcher, PD Middlemiss, DN White, A Hagan, JJ
Citation: Dnc. Jones et al., Influence of peptide CRF receptor antagonists upon the behavioural effectsof human rat CRF, EUR J PHARM, 373(2-3), 1999, pp. 141-145
The effects of dopamine D-3/D-2 receptor agonists on intracranial self stimulation in the rat
Authors: Hatcher, JP Hagan, JJ
Citation: Jp. Hatcher et Jj. Hagan, The effects of dopamine D-3/D-2 receptor agonists on intracranial self stimulation in the rat, PSYCHOPHAR, 140(4), 1998, pp. 405-410
A comparison of rectal and subcutaneous body temperature measurement in the common marmoset
Authors: Cilia, J Piper, DC Upton, N Hagan, JJ
Citation: J. Cilia et al., A comparison of rectal and subcutaneous body temperature measurement in the common marmoset, J PHARM TOX, 40(1), 1998, pp. 21-26
Risultati: 1-22 |